Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 713 | 3071 | 36.6 | 77% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 1006 | 9881 | STREPTOCOCCUS SUIS//GROUP A STREPTOCOCCI//STREPTOCOCCUS PYOGENES |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | STREPTOCOCCUS PYOGENES | Author keyword | 237 | 45% | 13% | 396 |
| 2 | GROUP A STREPTOCOCCI | Author keyword | 168 | 46% | 9% | 269 |
| 3 | STREPTOCOCCAL TOXIC SHOCK SYNDROME | Author keyword | 58 | 73% | 1% | 45 |
| 4 | MOL TRANSLAT HUMAN INFECT DIS | Address | 47 | 53% | 2% | 62 |
| 5 | SPEB | Author keyword | 35 | 89% | 1% | 16 |
| 6 | M PROTEIN | Author keyword | 33 | 36% | 2% | 74 |
| 7 | EMM TYPE | Author keyword | 32 | 78% | 1% | 21 |
| 8 | EMM TYPING | Author keyword | 15 | 67% | 0% | 14 |
| 9 | STREPTOCOCCUS DYSGALACTIAE SUBSP EQUISIMILIS | Author keyword | 15 | 67% | 0% | 14 |
| 10 | EMM GENE | Author keyword | 15 | 82% | 0% | 9 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | STREPTOCOCCUS PYOGENES | 237 | 45% | 13% | 396 | Search STREPTOCOCCUS+PYOGENES | Search STREPTOCOCCUS+PYOGENES |
| 2 | GROUP A STREPTOCOCCI | 168 | 46% | 9% | 269 | Search GROUP+A+STREPTOCOCCI | Search GROUP+A+STREPTOCOCCI |
| 3 | STREPTOCOCCAL TOXIC SHOCK SYNDROME | 58 | 73% | 1% | 45 | Search STREPTOCOCCAL+TOXIC+SHOCK+SYNDROME | Search STREPTOCOCCAL+TOXIC+SHOCK+SYNDROME |
| 4 | SPEB | 35 | 89% | 1% | 16 | Search SPEB | Search SPEB |
| 5 | M PROTEIN | 33 | 36% | 2% | 74 | Search M+PROTEIN | Search M+PROTEIN |
| 6 | EMM TYPE | 32 | 78% | 1% | 21 | Search EMM+TYPE | Search EMM+TYPE |
| 7 | EMM TYPING | 15 | 67% | 0% | 14 | Search EMM+TYPING | Search EMM+TYPING |
| 8 | STREPTOCOCCUS DYSGALACTIAE SUBSP EQUISIMILIS | 15 | 67% | 0% | 14 | Search STREPTOCOCCUS+DYSGALACTIAE+SUBSP+EQUISIMILIS | Search STREPTOCOCCUS+DYSGALACTIAE+SUBSP+EQUISIMILIS |
| 9 | EMM GENE | 15 | 82% | 0% | 9 | Search EMM+GENE | Search EMM+GENE |
| 10 | STREPTOCOCCAL PYROGENIC EXOTOXIN B | 15 | 82% | 0% | 9 | Search STREPTOCOCCAL+PYROGENIC+EXOTOXIN+B | Search STREPTOCOCCAL+PYROGENIC+EXOTOXIN+B |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | PYOGENES | 701 | 55% | 29% | 876 |
| 2 | GROUP A STREPTOCOCCI | 573 | 38% | 39% | 1202 |
| 3 | HYALURONIC ACID CAPSULE | 288 | 84% | 5% | 159 |
| 4 | SHOCK LIKE SYNDROME | 244 | 69% | 7% | 211 |
| 5 | M PROTEIN | 235 | 51% | 11% | 333 |
| 6 | EXTRACELLULAR CYSTEINE PROTEASE | 143 | 87% | 2% | 69 |
| 7 | VIR REGULON | 114 | 95% | 1% | 38 |
| 8 | SCARLET FEVER TOXIN | 84 | 76% | 2% | 58 |
| 9 | INVASIVE GROUP | 81 | 60% | 3% | 89 |
| 10 | SERUM OPACITY FACTOR | 76 | 77% | 2% | 51 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| Pathogenesis of group A streptococcal infections | 2000 | 1083 | 411 | 69% |
| Disease Manifestations and Pathogenic Mechanisms of Group A Streptococcus | 2014 | 26 | 556 | 67% |
| Molecular insight into invasive group A streptococcal disease | 2011 | 70 | 152 | 78% |
| Global emm type distribution of group A streptococci: systematic review and implications for vaccine development | 2009 | 132 | 24 | 75% |
| Molecular basis of group A streptococcal virulence | 2003 | 240 | 127 | 86% |
| Geoepidemiological hints about Streptococcus pyogenes strains in relationship with acute rheumatic fever | 2015 | 1 | 72 | 71% |
| Invasive Group A Streptococcal Disease Epidemiology, Pathogenesis and Management | 2012 | 32 | 123 | 68% |
| The streptococcal M protein: a highly versatile molecule | 2010 | 43 | 95 | 88% |
| The global burden of group A streptococcal diseases | 2005 | 744 | 37 | 24% |
| Group A streptococcal vaccines: Paving a path for accelerated development | 2013 | 13 | 50 | 82% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | MOL TRANSLAT HUMAN INFECT DIS | 47 | 53% | 2.0% | 62 |
| 2 | HUMAN BACTERIAL PATHOGENESIS | 12 | 18% | 2.1% | 63 |
| 3 | MICROBIAL PATHOGENESIS VACCINE | 10 | 43% | 0.6% | 18 |
| 4 | ABORATING REFERENCE STREPTOCOCCI | 9 | 59% | 0.3% | 10 |
| 5 | ORAL MOL MICROBIOL | 9 | 28% | 0.8% | 26 |
| 6 | MICROBIOL PATHOGENESIS VACCINE | 8 | 100% | 0.2% | 5 |
| 7 | STUDY HUMAN BACTERIAL PATHOGENESIS | 7 | 48% | 0.4% | 11 |
| 8 | BACTERIAL PATHOGENESIS | 7 | 21% | 0.9% | 27 |
| 9 | SECT MOL PATHOGENESIS | 5 | 23% | 0.7% | 20 |
| 10 | P DIS BRANCH | 5 | 11% | 1.5% | 45 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000161208 | STRANGLES//STREPTOCOCCUS EQUI//STREPTOCOCCUS EQUI SSP ZOOEPIDEMICUS |
| 2 | 0.0000111390 | RHEUMATIC FEVER//PANDAS//SYDENHAMS CHOREA |
| 3 | 0.0000087367 | PHARYNGITIS//STREPTOCOCCAL PHARYNGITIS//THROAT CULTURE |
| 4 | 0.0000083462 | NECROTIZING FASCIITIS//FOURNIERS GANGRENE//NECROTISING FASCIITIS |
| 5 | 0.0000078428 | SORTASE//SORTASE A//SRTA |
| 6 | 0.0000075725 | NEPHRITIS ASSOCIATED PLASMIN RECEPTOR//ACUTE GLOMERULONEPHRITIS//ACUTE POSTSTREPTOCOCCAL GLOMERULONEPHRITIS |
| 7 | 0.0000072236 | TELITHROMYCIN//MACROLIDE RESISTANCE//CEFDITOREN |
| 8 | 0.0000070220 | THEODORE GILDRED CANC//PROTEIN L//STAPHYLOCOCCAL PROTEIN A |
| 9 | 0.0000065594 | LUBROL W 1//STREPTOCOCCUS PYOGENES GROUP A//STREPTOLYSIN S |
| 10 | 0.0000062596 | SUPERANTIGEN//STAPHYLOCOCCAL ENTEROTOXIN B//SUPERANTIGENS |